Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial.

Burger M, Thiounn N, Denzinger S, Kondas J, Benoit G, Chapado MS, Jimenz-Cruz FJ, Kisbenedek L, Szabo Z, Zsolt D, Grimm MO, Romics I, Thüroff JW, Kiss T, Tombal B, Wirth M, Munsell M, Mills B, Koh T, Sherman J.

J Transl Med. 2010 Jun 8;8:54. doi: 10.1186/1479-5876-8-54.

2.

Effect of dutasteride on the risk of prostate cancer.

Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS; REDUCE Study Group.

N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.

3.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H.

Eur Urol. 2008 Mar;53(3):478-96. doi: 10.1016/j.eururo.2007.12.024. Epub 2007 Dec 26. Review.

PMID:
18191324
4.

European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Paz-Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H.

Eur Urol. 2008 Mar;53(3):497-513. doi: 10.1016/j.eururo.2007.12.025. Epub 2007 Dec 26.

PMID:
18191015
5.

Administration of estramustine in response to changes in the prostate-specific antigen and Karnofsky index in the treatment of prostate cancer.

Pintér O, Molnár J, Tóth C, Szabó Z, Lipták J, Fél P, Papp G, Hollman E, Hazay L, Streit B, Kisbenedek L, Fehér M, Kocsis I, Pajor L.

In Vivo. 2005 Jul-Aug;19(4):787-92.

6.

[The place of estramustine in the treatment of prostate cancer].

Pintér O, Tóth C, Szabó Z, Lipták J, Fél P, Papp G, Holman E, Hazay L, Streit B, Kisbenedek L, Fehér M, Kocsis I.

Orv Hetil. 2005 Mar 20;146(12):553-7. Hungarian.

PMID:
15853064
7.

European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).

Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M, Derigs HG, Dieckmann KP, Flasshove M, Garcia del Muro X, Gerl A, Germa-Lluch JR, Hartmann M, Heidenreich A, Hoeltl W, Joffe J, Jones W, Kaiser G, Klepp O, Kliesch S, Kisbenedek L, Koehrmann KU, Kuczyk M, Laguna MP, Leiva O, Loy V, Mason MD, Mead GM, Mueller RP, Nicolai N, Oosterhof GO, Pottek T, Rick O, Schmidberger H, Sedlmayer F, Siegert W, Studer U, Tjulandin S, von der Maase H, Walz P, Weinknecht S, Weissbach L, Winter E, Wittekind C; European Germ Cell Cancer Consensus Group.

Ann Oncol. 2004 Sep;15(9):1377-99. Review.

PMID:
15319245
8.

[Early diagnosis of testicular cancer]

Géczi L, Horváth Z, Beczássy E, Kisbenedek L, Bak M, Bodrogi I.

Magy Onkol. 2000 Dec 1;44(4):275-283. Hungarian.

9.

EAU guidelines on testicular cancer.

Laguna MP, Pizzocaro G, Klepp O, Algaba F, Kisbenedek L, Leiva O; EAU Working Group on Oncological Urology.

Eur Urol. 2001 Aug;40(2):102-10.

PMID:
11528185
10.

The use of valrubicin for the chemoresection of superficial bladder cancer -- a marker lesion study.

Newling DW, Hetherington J, Sundaram SK, Robinson MR, Kisbenedek L.

Eur Urol. 2001 Jun;39(6):643-7.

PMID:
11464052
11.

Three-year results of the first educational and early detection program for testicular cancer in Hungary.

Géczi L, Gomez F, Horváth Z, Bak M, Kisbenedek L, Bodrogi I.

Oncology. 2001;60(3):228-34.

PMID:
11340374
12.
13.

[Primary lymphoma of the bladder].

Pecze K, Kisbenedek L, Szepesházi K, Jakab I.

Orv Hetil. 1990 Sep 9;131(36):1979-81. Review. Hungarian.

PMID:
2216422
14.

[The role of percutaneous puncture of the kidney pelvis in urologic practice].

Hamvas A, Kisbenedek L, Pajor L.

Orv Hetil. 1984 Nov 18;125(47):2857-61. Hungarian. No abstract available.

PMID:
6504520
15.

[Percutaneous nephrostomy in the management of septic pyelonephritis in pregnancy].

Pajor L, Kisbenedek L, Hamvas A, Répássy D.

Orv Hetil. 1983 Sep 25;124(39):2369-71. Hungarian. No abstract available.

PMID:
6646720
16.

[Clinical value of immunologic studies in patients with bladder tumors].

Romics I, Fehér J, Kisbenedek L, Horváth J, Balogh F.

Z Urol Nephrol. 1983;76(2):79-85. German.

PMID:
6190325
17.

Vesicoureteral reflux following transurethral resection of bladder tumours at the ureteral orifice.

Kisbenedek L, Szeldeli P, Biró G, Balogh F.

Eur Urol. 1982;8(1):9-10. No abstract available.

PMID:
7060613
18.

The investigation of cellular and humoral immune reactivity in patients with tumours of the bladder.

Romics I, Fehér J, Horváth J, Kisbenedek L, Balogh F.

Int Urol Nephrol. 1982;14(3):269-73.

PMID:
6186627
19.

Transurethral resection (TUR) in the therapy of bladder tumors (a review of 483 cases).

Balogh F, Kisbenedek L.

Int Urol Nephrol. 1982;14(2):143-9. No abstract available.

PMID:
6181002
20.

Endoscopic control of post-adenomectomy bleedings.

Kisbenedek L, Hazay L, Balogh F.

Eur Urol. 1982;8(3):161-2. No abstract available.

PMID:
6176453

Supplemental Content

Loading ...
Support Center